Xilio Therapeutics, Inc. Common Stock (XLO)

Typically moves ±9.37% on earnings
EARNINGS ANALYTICS
event_upcoming Est. Next Earnings: 2026-11-10 ESTIMATED
search

Xilio Therapeutics, Inc. Common Stock (XLO) has a 20-report earnings history dating back to Dec 02, 2021. Its average absolute post-earnings move is ±9.37%, and 50.0% of those reactions were positive. Its largest post-earnings gain was +81.9% (Mar 28, 2024) and its largest decline was -21.88% (Aug 09, 2022). The next earnings report is predicted for 2026-11-10 (estimated).

Earnings reactions

How XLO moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

20

Avg Abs. Movement

±9.37%

Positive %

50.0%

Negative %

50.0%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
Aug 12, 2026 ☀ PRE +0% open_in_new
May 12, 2026 ☀ PRE -0.51% open_in_new
Mar 23, 2026 ☀ PRE +2.56% open_in_new
Nov 13, 2025 ☀ PRE -8.47% open_in_new
event

Earnings Count

20

Total earnings in dataset

trending_up

Avg Abs. Movement

±9.37%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 8 →
8
Funds holding
$8004309
Total value held
Buying
4 added · 1 reduced
Gilead Sciences, Inc.
$6230727 Held
Merck & Co., Inc.
$1015308 Held
Morgan Stanley
$545619 -0.94%
State Street Corp
$127519 Held
Blackrock, Inc.
$83892 NEW BUY

SEC Filing Types

Recent SEC Filings

10 most recent
Form Date Filed View on EDGAR
SCHEDULE 13G/A 20260814 open_in_new SEC.gov
10-Q 20260812 open_in_new SEC.gov
8-K 20260812 open_in_new SEC.gov
S-8 20260812 open_in_new SEC.gov
4 20260612 open_in_new SEC.gov
4 20260612 open_in_new SEC.gov
4 20260612 open_in_new SEC.gov
4 20260612 open_in_new SEC.gov
4 20260612 open_in_new SEC.gov
4 20260612 open_in_new SEC.gov

Frequently asked about XLO earnings

When does Xilio Therapeutics, Inc. Common Stock report earnings next? expand_more

Xilio Therapeutics, Inc. Common Stock (XLO)'s next earnings date is estimated for 2026-11-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does XLO stock move after earnings? expand_more

Over 20 reports, XLO has moved an average of ±9.37% the session after earnings, closing higher 50.0% of the time.

What was XLO's biggest post-earnings move? expand_more

XLO's largest post-earnings gain on record was +81.9% on Mar 28, 2024, and its largest decline was -21.88% on Aug 09, 2022.

Where can I find Xilio Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of Xilio Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Sector peers